Prevention of malaria in long-term travelers

JAMA

Volumn 296, Issue 18, 2006, Pages 2234-2244

  Chen, Lin H ^a,b   Wilson, Mary E ^a,b,c   Schlagenhauf, Patricia ^d  

^a MOUNT AUBURN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; HYDROXYCHLOROQUINE; INSECT REPELLENT; MEFLOQUINE; METOCLOPRAMIDE; PARACETAMOL; PRIMAQUINE; PROGUANIL;

ABDOMINAL PAIN; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG TOLERABILITY; EYE TOXICITY; HUMAN; INCIDENCE; INSOMNIA; LONG TERM CARE; MALARIA; MEDICAL SPECIALIST; MOUTH ULCER; NAUSEA; PHOTOSENSITIVITY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PROTECTIVE EQUIPMENT; REVIEW; RISK FACTOR; SELF MEDICATION; TABLET FORMULATION; TRAVEL; UNSPECIFIED SIDE EFFECT; VIVID DREAM; VOMITING;

EID: 33750696938     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.18.2234     Document Type: Review

References (100)

1. World Tourism Organization (WTO). UNWTO World Tourism Barometer: international tourist arrivals. January 2006. http://www.world-tourism.org/ facts/menu.html. Accessed March 5, 2006.
2. Leder K, Black J, O'Brien D, et al. Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis. 2004;39:1104-1112.
3. Hughes C, Tucker R, Bannister B, Bradley DJ; Health Protection Agency Advisory Committee on Malaria Prevention for UK Travellers (ACMP). Malaria prophylaxis for long-term travelers. Commun Dis Public Health. 2003;6:200-208.
4. World Health Organization (WHO). Malaria. In: International Travel and Health. Geneva, Switzerland: WHO; 2005:132-151. http://whqlibdoc.who.int/ publications/2005/9241580364_chap7.pdf. Accessed July 14, 2006.
5. Muentener P, Schlagenhauf P, Steffen R. Imported malaria (1985-95): trends and perspectives. Bull World Health Organ. 1999;77:560-566.
6. Steffen R, Heusser R, Machler R, et al. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions and efficacy. Bull World Health Organ. 1990;68:313-322.
7. Jelinek T, Bluml A, Loscher T, Nothdurft H-D. Assessing the incidence of infection with Plasmodium falciparum among international travelers. Am J Trop Med Hyg. 1998;59:35-37.
8. Askling HH, Nilsson J, Tegnell A, Janzon R, Ekdahl K. Risk of malaria in travelers returning from malaria endemic regions. Emerg Infect Dis. 2005;11:436-441.
9. Ross MH, Hodge M. Malaria in expatriate mine workers [poster paper]. In: Conference Proceedings of Minesafe International 2000. Perth, Australia: Minesafe; 2000:533-536.
10. Blanke CH. Increased malaria-morbidity of longterm travellers due to inappropriate chemoprophylaxis recommendations. Trop Doct. 2003;33:117-119.
11. Leutscher PD, Bagley SW. Health-related challenges in United States Peace Corps Volunteers serving for two years in Madagascar. J Travel Med. 2003;10:263-267.
12. Adera T, Wolfe MS, McGuire-Rugh K, Calhoun N, Marum L. Risk factors for malaria among expatriates living in Kampala, Uganda: the need for adherence to chemoprophylactic regimens. Am J Trop Med Hyg. 1995;52:207-212.
13. Peppiatt R, Byass P. A survey of the health of British missionaries. Br J Gen Pract. 1991;41:159-162.
14. Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ. Risk of malaria in British residents returning from malarious areas. BMJ. 1990;300:499-503.
15. Lange WR, Kreider SD, Kaczaniuk MA, Snyder FR. Missionary health: the great omission. Am J Prev Med. 1987;3:332-338.
16. McLarty DG, Webber RH, Marjatta Jaatinen LM, et al. Chemoprophylaxis of malaria in nonimmune residents in Dar es Salaam, Tanzania. Lancet. 1984;2:656-659.
17. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet. 2004;364:1896-1898.
18. Causer LM, Filler S, Wilson M, Papagiotas S, Newman RD. Evaluation of reported malaria chemoprophylactic failure among travelers in a US University Exchange Program, 2002. Clin Infect Dis. 2004;39:1583-1588.
19. Reyburn H, Mbatia R, Drakely C, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study [published online ahead of print November 12, 2004]. BMJ. 2004;329:1212. doi:10.1136/bmj.38251.658229.55. Accessed November 20, 2004.
20. Alweis RL, DiRosario K, Conidi G, Kain KC, Olans R, Tully JL. Serial nosocomial transmission of Plasmodium falciparum malaria from patient to nurse to patient. Infect Control Hosp Epidemiol. 2004;25:55-59.
21. Schlagenhauf-Lawlor P, Funk-Baumann M. PDQ Traveler's Malaria. Hamilton, Ontario:BCDecker; 2005.
22. Keiser J, Singer BH, Utzinger J. Reducing the burden of malaria in different eco-epidemiological settings with environmental management: a systematic review. Lancet Infect Dis. 2005;5:695-708.
23. Soto J, Medina F, Dember N, Berman J. Efficacy of permethrin-impregnated uniforms in the prevention of malaria and leishmaniasis in Colombian soldiers. Clin Infect Dis. 1995;21:599-602.
24. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;(2):CD000363.
25. Nasci R. Pre- and post-travel general health recommendations: protection against mosquitoes and other arthropods. In: Arguin PM, Kozarsky PE, Navin AW,eds. Health Information for International Travel, 2005-2006. Atlanta, Ga: US Dept of Health and Human Services, Public Health Service; 2005:24-28. http://www2.ncid.cdc.gov/travel/yb/utils/ybGet.asp?section=recs&obj=bugs. htm&cssNav=browseoyb. Accessed October 5, 2005.
26. Insect repellents. Med Lett Drugs Ther. 2003;45:41-42.
27. McGready R, Hamilton KA, Simpson JA, et al. Safety of the insect repellent N,N-diethyl-m-toluamide (DEET) in pregnancy. Am J Trop Med Hyg. 2001;65:285-289.
28. American Academy of Pediatrics. Follow safety precautions when using DEET on children. http://www.aap.org/family/wnv-jun03.htm. Accessed July 14, 2006.
29. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med. 2002;347:13-18.
30. Frances SP, Van Dung N, Beebe NW, Debboun M. Field evaluation of repellent formulations against daytime and nighttime biting mosquitoes in a tropical rainforest in northern Australia. J Med Entomol. 2002;39:541-544.
31. Badolo A, Ilboudo-Sanogo E, Ouedraogo AP, Costantini C. Evaluation of the sensitivity of Aedes aegypti and Anopheles gambiae complex mosquitoes to two insect repellents: DEET and KBR 3023. Trop Med Int Health. 2004;9:330-334.
32. Frances SP, Waterson DG, Beebe NW, Cooper RD. Field evaluation of repellent formulations containing deet and picaridin against mosquitoes in Northern Territory, Australia. J Med Entomol. 2004;41:414-417.
33. Costantini C, Badolo A, Ilboudo-Sanogo E. Field evaluation of the efficacy and persistence of insect repellents DEET, IR3535, and KBR 3023 against Anopheles gambiae complex and other Afrotropical vector mosquitoes. Trans R Soc Trop Med Hyg. 2004;98:644-652.
34. Trigg JK. Evaluation of a eucalyptus-based repellent against Anopheles spp. in Tanzania. J Am Mosq Control Assoc. 1996;12:243-246.
35. Govere J, Durrheim DN, Baker L, Hunt R, Coetzee M. Efficacy of three insect repellents against the malaria vector Anopheles arabiensis. Med Vet Entomol. 2000;14:441-444.
36. Moore SJ, Lenglet A, Hill N. Field evaluation of three plant-based insect repellents against malaria vectors in Vaca Diez Province, the Bolivian Amazon. J Am Mosq Control Assoc. 2002;18:107-110.
37. Trongtokit Y, Curtis CF, Rongsriyam Y. Efficacy of repellent products against caged and free flying Anopheles stephensi mosquitoes. Southeast Asian J Trop Med Public Health. 2005;36:1423-1431.
38. Harris AF, Matias-Arnez A, Hill N. Biting time of Anopheles darlingi in the Bolivian Amazon and implications for control of malaria. Trans R Soc Trop Med Hyg. 2006;100:45-47.
39. Govere J, Braack LE, Durrheim DN, Hunt RH, Coetzee M. Repellent effects on Anopheles arabiensis biting humans in Kruger Park, South Africa. Med Vet Entomol. 2001;15:287-292.
40. Durrheim DN, Govere JM. Malaria outbreak control in an African village by community application of "deet" mosquito repellent to ankles and feet. Med Vet Entomol. 2002;16:112-115.
41. Steffen R, Holdener F, Wyss RK, Nurminen L. Malaria prophylaxis and self-therapy in airline crews. Aviat Space Environ Med. 1990;61:942-945.
42. Public Health Agency of Canada. Canadian recommendations for the prevention and treatment of malaria among international travellers: malaria prevention in the long-term traveller or expatriate. Can Comm Dis Rep. 2004;30(suppl 1). http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/04vol30/30s1/ page5_e.html. Accessed March 21, 2006.
43. Burdon J. Use of malarial prophylaxis amongst a population of expatriate church workers in Northeast Zaire. J Travel Med. 1998;5:36-38.
44. Weber R, Schlagenhauf P, Amsler L, Steffen R. Knowledge, attitudes and practices of business travelers regarding malaria risk and prevention. J Travel Med. 2003;10:219-224.
45. Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med. 1998;128:931-940.
46. Parise M, Barber A, Mali S. Prevention of specific infectious diseases: malaria. In: Arguin M, Kozarsky PE, Navin AW, eds. Health Information for International Travel, 2005-2006. Atlanta, Ga: US Dept of Health and Human Services, Public Health Service; 2005:189-212. http://www2.ncid.cdc.gov/travel/ yb/util/ybGetasap?section=disc&obj=index.htm&cssNav=browseoyb. Accessed October 5, 2006.
47. Chen LH, Keystone JS. New strategies for the prevention of malaria in travelers. Infect Dis Clin North Am. 2005;19:185-210.
48. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet. 1993;341:848-851.
49. Overbosch D. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries. J Travel Med. 2003(10 suppl 1):S16-S20, S21-S23.
50. Shanks GD, Roessler F, Edstein MD, Rieckmann KH. Doxycycline for malaria prophylaxis in Australian soldiers deployed to United Nations missions in Somalia and Cambodia. Mil Med. 1995;160:443-445.
51. Fryauff DJ, Baird JK, Basri H, et al. Randomized, placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria in Indonesia. Lancet. 1995;346:1190-1193.
52. Pennie RA, Koren G, Crevoisier C. Steady state pharmacokinetics of mefloquine in long-term travellers. Trans R Soc Trop Med Hyg. 1993;87:459-462.
53. Rombo L, Angel VH, Friman G, Hellgren U, Mittelholzer ML, Sturchler D. Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers. Trop Med Parasitol. 1993;44:254-256.
54. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet. 1993;341:1299-1303.
55. Croft AM, World MJ. Neuropsychiatric reactions with mefloquine chemoprophylaxis. Lancet. 1996;347:326.
56. Schlagenhauf P, Lobel H, Steffen R, et al. Tolerance of mefloquine by SwissAir trainee pilots. Am J Trop Med Hyg. 1997;56:235-240.
57. Schlagenhauf P, Tschop A, Johnson R, et al. Tolerability of malaria chemoprophylaxis in nonimmune travelers to sub-Saharan Africa: multicentre, randomized, double blind, four-arm study. BMJ. 2003;327:1078-1083.
58. Wells TS, Smith TC, Smith B, et al. Mefloquine use and hospitalizations among US service members, 2002-2004. Am J Trop Med Hyg. 2006;74:744-749.
59. Peragallo MS, Sabatinelli G, Sarnicola G. Compliance and tolerability of mefloquine and chloroquine plus proguanil for long-term malaria chemoprophylaxis in groups at particular risk (the military). Trans R Soc Trop Med Hyg. 1999;93:73-77.
60. Hopperus Buma AP, van Thiel PP, Lobel HO, et al. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis. 1996;173:1506-1509.
61. Raoult D, Houpikian P, Dupont HT, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. 1999;159:167-173.
62. Baird JK, Lacy MD, Basri H, et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis. 2001;33:1990-1997.
63. Chatterjee S. Compliance of malaria chemoprophylaxis among travelers to India. J Travel Med. 1999;6:7-11.
64. Fegan D, Glennon J. Malaria prophylaxis in longterm expatriate mineworkers in Ghana. Occup Med (Lond). 1993;43:135-138.
65. Dwelle TL. Inadequate basic preventive health measures: survey of missionary children in sub-Saharan Africa. Pediatrics. 1995;95:733-737.
66. Maarschalk T, Ross MH, de Frey AF. Attitudes, knowledge, beliefs and practices regarding malaria prophylaxis in expatriate mine workers in the Zambian Copperbelt. Occupational Health Southern Africa. 2006;12:16-20.
67. Hamer DH, Ruffing R, Lyons S, Dornbusch J, Callahan MV. Use of antimalarial prophylaxis by expatriates at an industrial job site in West Africa [abstract]. Presented at: 8th Conference of the International Society of Travel Medicine; May 7-11, 2003; New York, NY.
68. World Health Organization. Development of recommendations for the protection of short-stay travelers to malaria endemic areas: memorandum from two WHO meetings. Bull World Health Organ. 1988;66:177-196.
69. Schlagenhauf P, Steffen R. Stand-by treatment of malaria in travelers: a review. J Trop Med Hyg. 1994;97:151-160.
70. Schlagenhauf P, Steffen R, Tschopp A, et al. Behavioural aspects of travelers in their use of malaria presumptive treatment. Bull World Health Organ. 1995;73:215-221.
71. Nothdurft HD, Jelinek T, Pechel SM, et al. Standby treatment of suspected malaria in travelers. Trop Med Parasitol. 1995;46:161-163.
72. Lampe AS, Bakker RB, Smith SJ. Dangers of antimalarial standby treatment. Eur J Clin Microbiol Infect Dis. 1994;13:322.
73. Hatz C, Beck B, Blum J, et al. Supplementum 1: Malariaschutz für Kurzzeitaufenthalter. BAG Bull. March 2006. http://www.bag.admin.ch/themen/ medizin/00682/00684/02535/index.html?lang=fr. Accessed July 23, 2006.
74. Behrens RH, Bisoffi Z, Bjorkman A, et al. Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent. Malar J. 2006;5:7.
75. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg. 1991;45:86-91.
76. Phillips-Howard PA, Behrens RH, Dunlop J. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria. Lancet. 1989;2:803-804.
77. US Centers for Disease Control and Prevention (CDC). Sudden death in a traveler following halofantrine administration - Togo, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:169-170, 179.
78. Trachsler M, Schlagenhauf P, Steffen R. Feasibility of a rapid dipstick antigen-capture assay for self-testing of travellers' malaria. Trop Med Int Health. 1999;4:442-447.
79. Funk M, Schlagenhauf P, Tschopp A, Steffen R. MalaQuick versus ParaSight F as a diagnostic aid in travellers' malaria. Trans R Soc Trop Med Hyg. 1999;93:268-272.
80. Grobusch MP, Hanscheid T, Gobels K, et al. Comparison of three antigen detection tests for diagnosis and follow-up of falciparum malaria in travellers returning to Berlin, Germany. Parasitol Res. 2003;89:354-357.
81. Whitty CJM, Armstrong M, Behrens RH. Self-testing for falciparum malaria with antigen-capture cards by travelers with symptoms of malaria. Am J Trop Med Hyg. 2000;63:295-297.
82. Jorgensen P, Chanthap L, Rebueno A, Tsuyuoka R, Bell D. Malaria rapid diagnostic tests in tropical climates: the need for a cool chain. Am J Trop Med Hyg. 2006;74:750-754.
83. Aldhous P. Murder by medicine. Nature. 2005;434:132-136.
84. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005;2:e100.
85. Newton PN, McGready R, Fernandez F, et al. Manslaughter by fake artesunate in Asia - will Africa be next? PLoS Med. 2006;3:e197.
86. Newton PN, Green MD, Fernandez FM, Day NPJ, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis. 2006;6:602-613.
87. Knobloch J. Long-term malaria prophylaxis for travelers. J Travel Med. 2004;11:374-378.
88. Muhlberger N, Jelinek T, Gascon J, et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J. 2004;3:5.
89. Schwartz E, Sidi Y. New aspects of malaria imported from Ethiopia. Clin Infect Dis. 1998;26:1089-1091.
90. Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria - implications for chemoprophylaxis in travelers. N Engl J Med. 2003;349:1510-1516.
91. Elliott JH, O'Brien D, Leder K, et al. Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers. J Travel Med. 2004;11:213-217.
92. Filler S, Causer LM, Newman RD, et al. Malaria surveillance - United States, 2001. MMWR Surveill Summ. 2003;52:1-14.
93. Eliades MJ, Shah S, Nguyen-Dinh P, et al. Malaria surveillance - United States, 2003. MMWR Surveill Summ. 2005;54:25-39.
94. Skarbinski J, Eliades MJ, Causer LM, et al. Malaria Surveillance - United States, 2004. MMWR Surveill Summ. 2006;55:23-37.
95. Funk-Baumann M. Geographic distribution of malaria at traveler destinations. In: Schlagenhauf-Lawlor P, ed. Travelers' Malaria. Hamilton, Ontario: BC Decker; 2001:56-93.
96. Edgcomb JH, Arnold J, Yount EH Jr, et al. Primaquine, SN 13272, a new curative agent in vivax malaria: a preliminary report. J Natl Malar Soc. 1950;9:285-292.
97. Garrison PL, Hankey DD, Coker WG, et al. Cure of Korean vivax malaria with pamaquine and primaquine. J Am Med Assoc. 1952;149:1562-1563.
98. Hill DR, Baird K, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report from CDC Expert Meeting on Malaria Chemoprophylaxis. Am J Trop Med Hyg. 2006;75:402-415.
99. Jelinek T, Nothdurft HD, Von Sonnenburg F, Loscher T. Long-term efficacy of primaquine in the treatment of vivax malaria in nonimmune travelers. Am J Trop Med Hyg. 1995;52:322-324.
100. Alving AS, Arnold J, Hockwald RS, et al. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med. 1955;46:301-306.